Calidi Biotherapeutics Inc. (CLDI) — Financial Flexibility Index
Calidi Biotherapeutics Inc. (CLDI) has a Financial Flexibility Index of -0.98x as of December 2025. Free cash flow of $-5.01 Million (operating CF $-5.04 Million minus capex $29.00K) represents -1% of total liabilities ($5.10 Million). Also explore Calidi Biotherapeutics Inc. equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Calidi Biotherapeutics Inc. Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Calidi Biotherapeutics Inc. across 6 annual periods. See Calidi Biotherapeutics Inc. (CLDI) balance sheet quality index to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for Calidi Biotherapeutics Inc. (2020–2025)
Year-by-year free cash flow to debt coverage for Calidi Biotherapeutics Inc.. For the full company profile including market capitalisation, see CLDI market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.15x | $-21.17 Million | $-21.29 Million | $5.10 Million | ▼ -157.8% |
| 2024 | -1.61x | $-19.68 Million | $-19.69 Million | $12.21 Million | ▼ -11.4% |
| 2023 | -1.45x | $-26.40 Million | $-26.98 Million | $18.25 Million | ▼ -499.9% |
| 2022 | -0.24x | $-12.79 Million | $-13.21 Million | $53.04 Million | ▲ +17.2% |
| 2021 | -0.29x | $-7.57 Million | $-7.77 Million | $26.00 Million | ▼ -58.3% |
| 2020 | -0.18x | $-4.47 Million | $-4.83 Million | $24.33 Million | — |